Market Publishers Ltd and Pharmaion Consultants Sign Partnership Agreement

23 Dec 2015 • by Natalie Aster

LONDON – Market Publishers Ltd and Pharmaion Consultants signed a partnership agreement for quality market research promotion on Internet. is now authorised to distribute and sell research reports elaborated by Pharmaion Consultants.

Natalie Aster, Assistant Manager at Partners Department, commented on the partnership agreement as follows: “Pharmaion is a research based management consulting firm focused on identifying a wealth of unexplored opportunities in the healthcare and pharma industry. Led by a team of highly professional and devoted industry experts, Pharmaion equips customers with high-value consulting and market research services, thereby helping them identify novel market opportunities, driving forces and innovative ways to gain the market share.” She also added: “We are certain that our companies can build successful and fruitful business relationships based on mutual confidence and collaboration.”

New comprehensive studies by Pharmaion include but are not limited to:

Global Tissue Engineered Medical Devices Market Forecast and Opportunities, 2020. The world tissue engineered medical devices market is set to surpass USD 26 billion mark by 2020 due to the rising prevalence of diabetes, ageing population and surging demand for tissue engineered medical devices as against artificial implants. The North American region dominated the global tissue engineered medical devices market as of 2014, and is expected to keep on taking the lead till 2020. This is due to a high percentage of geriatric population as well as the economic stability in the region, which helps patients undergo expensive treatments. Depuy Synthes, Medtronic plc, Zimmer Biomet, Stryker Corporation, and Edwards Lifesciences Corporation, among others, are some of the dominant players in the global market. The study analyses the market size, volume, shares, and offers forecasts ...

United States Lipid Panel Testing Market Opportunities, 2010 – 2020. As the incidence rates of cholesterol associated diseases in the USA rise, the demand for lipid panel testing is also escalating across the country. Furthermore, increasing automation in labs resulting in higher sensitivity in tandem with faster tests result will likely give a boost to the country’s lipid panel testing market up to 2020. The report provides an analysis of the market size and share of the different segments and sub segments of the domestic lipid panel testing market during 2010-2020. The research publication canvasses the factors driving the market and also the challenges restraining its growth. It also idientifies and canvasses the major market trends, a granular analysis of the dynamic competitive landscape, and provides revenue forecasts for the market by segment and sub segment ...

Global Cervical Cancer Vaccine Market Opportunities, 2020. The global cervical cancer market is projected to surpass the USD 1.6 billion mark by 2020 on the back of an increase in the immunisation programmes for HPV vaccination, a hike in the prevalence of cervical cancer and also favourable government incentives to raise the awareness about the disease. Nevertheless, the unavailability of HPV vaccines in some geographies, unclear reimbursement rates, and changing regulatory guidelines are amid the factors restraining the market’s growth. As of 2014, the USA was the dominant consumer of cervical cancer vaccines, and the nation is set to continue its dominance in the offing due to the launch of a 9-valent HPV vaccine, Gardasil 9, as of 2014 which protects against the infection of all 9 types of HPV, in comparison to Gardasil that protects against only 4 HPV types. Two HPV vaccines approved by the FDA, namely, Merck’ Gardasil and GlaxoSmithKline’s Cervarix, are available from pole to pole. More data on the global cervical cancer vaccine market can be found in the research study ...

More details on the publisher and its studies can be found at Pharmaion Consultants page.


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970